Hilab Molecular
Medical Device
Hi Technologies Ltda.Hilab Molecular is the smallest and fastest molecular biology device, developed to reduce the time to deliver results of RT-PCR COVID-19 tests from 07 days to about 60 minutes. This device was created in 4 months, during the pandemic’s peak of Covid-19, in Brazil, and doesn’t require transport of biological samples, as we digitize test results at the point of care. The Hilab Molecular is linked to a platform that integrates AI, IoT, and cloud computing tools. Shortly it will be possible to use this device to bring health anywhere in the world, and to combat diseases such as HPV, dengue, zika, and chikungunya.
Client / ManufacturerDesign
Hi Technologies Ltda.
Curitiba, BRHi Technologies Ltda.
Curitiba, BRAdriano Timm, Alexandre de Bastiani, João Predebon, Luís Hartmann, Guilherme Calesco, Sérgio Rogal, Marcus FigueredoDate of Launch
2020
Development Time
up to 12 Month
Target Regions
South America
Target Groups
Consumers / Users, Trade / Industry, Public Sector / Government